JO
CLBT icon

John Overdeck’s Cellebrite CLBT Stock Holding History

John Overdeck’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
137,336
-94,586
-41% -$1.25M ﹤0.01% 2998
2026
Q1 		$3.2M Buy
231,922
+122,217
+111% +$1.84M ﹤0.01% 2392
2025
Q4 		$1.98M Sell
109,705
-77,738
-41% -$1.4M ﹤0.01% 2440
2025
Q3 		$3.47M Sell
187,443
-691,275
-79% -$10.9M 0.01% 1744
2025
Q2 		$14.1M Sell
878,718
-142,554
-14% -$2.54M 0.02% 676
2025
Q1 		$19.8M Sell
1,021,272
-328,387
-24% -$6.91M 0.04% 487
2024
Q4 		$29.7M Sell
1,349,659
-227,733
-14% -$4.38M 0.06% 363
2024
Q3 		$26.6M Buy
1,577,392
+216,694
+16% +$3.22M 0.06% 396
2024
Q2 		$16.3M Buy
1,360,698
+133,541
+11% +$1.49M 0.04% 532
2024
Q1 		$13.6M Sell
1,227,157
-71,645
-6% -$731K 0.03% 555
2023
Q4 		$11.2M Buy
1,298,802
+943,089
+265% +$7.33M 0.03% 620
2023
Q3 		$2.72M Buy
355,713
+225,339
+173% +$1.69M 0.01% 1214
2023
Q2 		$939K Buy
+130,374
New +$760K ﹤0.01% 1977

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

John Overdeck's CLBT Position: Q2 2026 in Review

John Overdeck reduced its Cellebrite (CLBT) stake by 41% in Q2 2026, selling an estimated $1.25M and leaving 137,336 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2998.

John Overdeck first reported a position in CLBT in Q2 2023 and has held it in 13 quarters since. The position peaked at $29.7M in Q4 2024. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • John Overdeck held 137,336 shares of Cellebrite worth $2.01M as of Q2 2026.
  • John Overdeck sold 94,586 Cellebrite shares in Q2 2026, an estimated $1.25M.
  • Cellebrite made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2998 holding.
  • John Overdeck first reported a position in Cellebrite in Q2 2023 and has held it in 13 quarters since.
  • John Overdeck's Cellebrite position peaked at $29.7M in Q4 2024.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.